Testing kidney transplant biopsy samples for better care
Part of Immune system & allergy clinical trials.
This study looks at kidney biopsy samples from adult kidney transplant recipients to help improve how transplant-related problems are diagnosed and treated. If you need a biopsy for medical reasons, you may be invited to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (18 or older)
- Have a kidney transplant
- Be scheduled for a kidney biopsy for medical reasons
- Be able and willing to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how genes affect kidney transplant outcomes. It asks you to give extra blood, urine, stool, and kidney tissue samples over time, so researchers can learn more about why some transplants work better than others.
This study looks at kidney transplant patients who are getting a kidney biopsy for usual clinical reasons. It tests whether special blood test results (from a sample taken as part of the study) can help spot transplant kidney problems earlier or more accurately.
This study checks samples from people after a kidney transplant to better understand how treatment is working at a biological (molecular) level. It may help doctors improve follow-up care and therapy over time.
This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This trial is about setting up and using a kidney-transplant database linked to stored blood/tissue samples. It may help researchers better understand kidney transplant outcomes and improve future care.
Hear when a new Validation Study of Molecular Diagnostic System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.